Quantcast

Latest Rodenticides Stories

2014-08-27 23:12:45

A study released August 1 highlights the challenges related to managing anticoagulant–associated intracerebral hemorrhage (AAICH). Washington, D.C. (PRWEB) August 27, 2014 A recently published study by the Journal of Neurosurgery discusses the importance of time in correcting coagulopathy to prevent permanent injury or death. The study focuses on a variety of anticoagulants and examines medical conditions alleged to be caused by these drugs. According to the research, although...

2014-07-30 23:01:48

The Firm is investigating Xarelto lawsuits on behalf of individuals who allegedly suffered uncontrollable bleeding, strokes, deep vein thrombosis, or pulmonary embolism due to the blood thinner. New York, New York (PRWEB) July 30, 2014 The family of a Vermont man who died from uncontrollable brain bleeding has filed a Xarelto lawsuit (http://www.xareltolawsuitcenter.com/ ) alleging his death was caused by the blood thinner, Bernstein Liebhard LLP reports. According to the complaint, which...

2014-07-15 12:23:54

RnRMarketResearch.com adds "Rodenticides Market by Type (Anticoagulants, Non-Anticoagulants, and Others), by End User (Agricultural Field, Warehouses, Pest Control Companies, Urban Centers, and Others) & by Geography - Global Trends & Forecasts to 2019" to its store. DALLAS, July 15, 2014 /PRNewswire-iReach/ -- The rodenticides market size is projected to increase due to the demand for food grains and rising farmers concerns over food wastage due to rodents. Rodenticides are also used in...

2014-05-30 12:22:42

Rodent control market leader reaches agreement with U.S. EPA to discontinue production of second generation pellets by December 31 PARSIPPANY, N.J., May 30, 2014 /PRNewswire/ -- d-CON®, America's number one rodent control brand, announced an agreement today with the U.S. Environmental Protection Agency (EPA) regarding the production and distribution of second generation rodenticide pellets. Certain d-CON® rodenticide products have been subject to a lengthy review by the EPA and,...

2014-05-13 12:27:29

IPRO-designed "MAP" Tool Addresses How to Handle Numerous Patient Situations, In Order to Reduce Risk of Both Excessive Bleeding and Formation of Blood Clots LAKE SUCCESS, N.Y., May 13, 2014 /PRNewswire-USNewswire/ -- A new, free-of-charge tool designed by the Peri-Procedural Task Force of the IPRO-led New York State Anticoagulation Coalition will enable clinicians to more easily determine how, whether and when to stop the use of warfarin and other anticoagulants prior to surgery and...

2014-05-12 11:38:13

Intermountain Medical Center Study included 2,600 AFib patients A new study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City has found that atrial fibrillation patients who are on blood thinning medications are at higher risk of developing dementia if their doses are not in the optimal recommended range. The study of more than 2,600 AFib patients found they are significantly more likely to develop dementia when using medicines to prevent blood...

2014-04-29 08:34:35

Recently Released ACC/AHA Practice Guidelines Reinforce Unmet Need MENLO PARK, Calif., April 29, 2014 /PRNewswire/ -- Armetheon, Inc., today announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the final pivotal trial of tecarfarin. Tecarfarin is positioned to be the only oral anticoagulant (OAC) therapy for patients with prosthetic heart valves (PHV) specifically identified in the label. In addition, the...

2014-03-26 23:27:31

Lead Investigator Discusses Findings With AJMC, Says Results Show Importance of Self-Testing Plainsboro, NJ (PRWEB) March 26, 2014 The American Journal of Managed Care (AJMC), on Monday published the results of the Self-Testing Analysis Based on Long-Term Experience (STABLE) study. It showed that self-testing significantly improves control of warfarin, as measured by time in therapeutic range (TTR). Results of the study, supported by Alere, were originally shared at the 2012 Scientific...

2014-03-13 00:21:16

DUBLIN, March 13, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/3d7f2f/aluminium) have announced the addition of the "Aluminium phosphide (CAS 20859-73-8) Market Research Report" [http://www.researchandmarkets.com/research/3d7f2f/aluminium ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Aluminium phosphide (CAS 20859-73-8) Market Research Report presents comprehensive data on aluminium...

2014-03-05 14:40:37

Although some research has suggested that the use of the anticoagulant warfarin for atrial fibrillation among patients with chronic kidney disease would increase the risk of death or stroke, a study that included more than 24,000 patients found a lower l-year risk of the combined outcomes of death, heart attack or stroke without a higher risk of bleeding, according to a study in the March 5 issue of JAMA. Juan Jesus Carrero, Ph.D., of the Karolinska Institutet, Stockholm, and colleagues...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.